欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (2): 121-129.doi: 10.12092/j.issn.1009-2501.2023.02.001

• 基础研究 •    下一篇

槲皮素干预肾间质成纤维细胞糖酵解抗肾间质纤维化机制研究

马月,马旺博,周智华,常静雯,范方田   

  1. 蚌埠医学院药学院,安徽省生化药物工程技术研究中心,蚌埠 233000,安徽
  • 收稿日期:2022-04-26 修回日期:2022-11-19 出版日期:2023-02-26 发布日期:2023-03-10
  • 通讯作者: 范方田,男,博士研究生,副教授,主要从事细胞异常代谢相关机制及中药的干预作用。 E-mail: fftian3912@163.com
  • 作者简介:马月,女,硕士研究生,主要从事细胞异常代谢相关机制及中药的干预作用。 E-mail: mayue2460@outlook.com
  • 基金资助:
    蚌埠医学院重大科技培育项目(2020byfy001);国家自然科学基金面上项目(81973658);中国博士后基金(一等资助)(2018M640529);安徽省教育厅优秀青年人才支持计划重点项目(gxyqZD2020027);蚌埠医学院2021年度研究生科研创新计划108项自筹经费立项项目(Byycxz21033)

Intervention of quercetin in glycolysis of renal interstitial fibroblasts against interstitial fibrosis mechanism

MA Yue, MA Wangbo, ZHOU Zhihua, CHANG Jingwen, FAN Fangtian   

  1. Bengbu Medical College, School of Pharmacy, Anhui Biochemical Pharmaceutical Engineering Technology Research Center, Bengbu 233000, Anhui, China
  • Received:2022-04-26 Revised:2022-11-19 Online:2023-02-26 Published:2023-03-10

摘要: 目的:从干预肾间质成纤维细胞的糖酵解角度研究槲皮素(Que)在体内外抗纤维化的作用和机制。方法:体内实验,小鼠分组给药,剖取肾脏,称重并进行组织病理学检查和生化指标检测;体外实验,不同试剂处理大鼠正常肾成纤维细胞(NRK-49F细胞),提取蛋白,采用蛋白免疫印迹(Western Blot)法检测NRK-49F细胞活化指标α平滑肌肌动蛋白(α-SMA)、增殖细胞核抗原(PCNA)等蛋白的表达情况;采用荧光法考查Que对转化生长因子-β(TGF-β1)和表皮细胞生长因子(EGF)诱导的NRK-49F细胞葡萄糖摄取的影响;乳酸检测试剂盒检测不同实验组细胞的乳酸含量;荧光定量PCR法检测Que对TGF-β1和EGF诱导的NRK-49F细胞糖酵解关键酶己糖激酶(HK2)、磷酸果糖激酶1(PFK1)和肌肉丙酮酸激酶同工酶2(PKM2)的mRNA的影响。结果:与UUO组比较,Que给药组肾脏组织形态结构均有不同程度的缓解,与抑制糖酵解有关,且小鼠血清中尿素氮(BUN)水平和血肌酐(Scr)水平呈现明显的下降趋势;NRK-49F细胞中乳酸生成和葡萄糖摄取量逐渐减少,Que对TGF-β1和EGF诱导的RIF的糖酵解关键酶的mRNA水平逐渐降低,并与PKM2有关。 结论:Que能够抑制NRK-49F细胞PKM2酶活性和糖酵解,并减少TGF-β1诱导的肌成纤维细胞活化。

关键词: 肾间质纤维化, 槲皮素, 糖酵解, PKM2

Abstract: AIM: To investigate the function and mechanism of quercetin (Que) in anti-fibrosis in vitro and in vivo from the perspective of interfering with the glycolysis of renal interstitial fibroblasts.  METHODS: In vivo experiments, mice were administered in groups, kidneys were dissected, weighed and examined histopathologically and biochemically; In vitro experiments, rat normal renal fibroblasts (NRK-49F cells) were treated with different reagents, proteins were extracted, and NRK-49F cell activation indicators such as α-smooth muscle actin (α-SMA) were detected by protein immunoblotting (Western Blot). The expression of the proteins, such as proliferating cell nuclear antigen (PCNA), was examined by protein immunoblotting (Western Blot), and the effect of Que on glucose uptake in NRK-49F cells induced by transforming growth factor-β (TGF-β1) and epidermal growth factor (EGF) was examined by fluorescence assay; the lactate content of cells in different experimental groups was examined by lactate assay kit; the effect of Que on glucose uptake in NRK-49F cells induced by TGF-β1 and EGF was examined by fluorescence quantitative PCR. EGF-induced mRNA of hexokinase (HK2), phosphofructokinase 1 (PFK1) and muscle pyruvate kinase isozyme 2 (PKM2), key enzymes of glycolysis in NRK-49F cells. RESULTS: Compared with the UUO group, the morphological structures of kidney tissues in the Que administration group were all alleviated to different degrees, which were related to the inhibition of glycolysis, and the serum levels of urea nitrogen (BUN) and blood creatinine (Scr) in mice showed a significant downward trend; lactate production and glucose uptake in NRK-49F cells were gradually reduced, and Que affected TGF-β1 and EGF-induced RIF of mRNA levels of key enzymes of glycolysis gradually decreased and were associated with PKM2. CONCLUSION: Que inhibits PKM2 enzyme activity and glycolysis in NRK-49F cells and reduces TGF-β1-induced myofibroblast activation.

Key words: renal interstitial fibrosis, quercetin, glycolysis, PKM2

中图分类号: